Skip to main content

Science
Products
Stories
Newsroom
About

Investors Media Careers Partners

Careers
Investors

Changed

Changed

How can we help you?

26 search results for igg

filterselect all | reset

Sort by

Order

Suggestions within Pfizer.com

Announcement

Article

Page

People Profiles

Podcast

Press Release

Product

filter select all | reset

Type

Announcement

Article

Page

People Profiles

Podcast

Press Release

Product

Date Range

Page 1
Page 2
Current page 3

Home
News
Press Releases

Press Release Archive

Press Releases

Year

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

Month

January

February

March

April

May

June

July

August

September

October

November

December

View 12

View 24

View 48

Categories

Corporate
Financial
Prescription Medicines
Research and Pipeline
Social Responsibility
Vaccines

Keywords

All Keywords

Covid-19
Finance
Investments
Leadership
Medicines
Partnerships
Research
Responsibility
Vaccines

June 2010

06.20.2010
Caduet Reduces 10-Year Calculated Risk Of Coronary Heart Disease, Fatal Cardiovascular Disease
06.16.2010
New CELEBREX® (celecoxib) Study Using Novel Endpoint, Published By The Lancet, Contributes to Knowledge Of NSAID-Associated Gastrointestinal Adverse Events
06.07.2010
Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference
06.04.2010
Phase 3 Study Showed MACUGEN® Improved Vision Over Standard Of Care In Patients With Diabetic Macular Edema
06.01.2010
Pfizer And Epocrates Partner To Give Healthcare Providers Access To Medical Information Specialists For Medication Questions

May 2010

05.26.2010
Pfizer Announces EMPHASIS-HF Trial To Halt Recruitment Due To Significant Benefit Observed In Patients Treated With Inspra® (Eplerenone)
05.25.2010
Pfizer Appoints Mikael Dolsten President Of Worldwide Research And Development
05.24.2010
Pfizer Animal Health Expands Global Commitment To A Safe Food Supply With A New Focus On Healthy Fish
05.19.2010
Pfizer Oncology To Present New Clinical Data From Ten Molecules Across Multiple Tumor Types
05.18.2010
Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference
05.18.2010
Pfizer Global Manufacturing Announces Plans To Reconfigure Its Global Plant Network
05.17.2010
Pfizer, Washington University Announce Groundbreaking Collaboration
05.05.2010
Pfizer Animal Health Announces First Recipients of New $2 Million Veterinary Scholarship Program
05.03.2010
Pfizer Reports First-Quarter 2010 Results; Reaffirms 2010 Financial Guidance

April 2010

04.23.2010
World Bank And Pfizer Announce Initiative To Help Improve Healthcare Delivery In Developing Countries
04.22.2010
Pfizer And Medicines For Malaria Venture Seek To Expand Fight Against Malaria With Intermittent Preventive Treatment Option For Pregnant Women
04.22.2010
Pfizer Discontinues Phase 3 Trial of Sutent® in Advanced Hepatocellular Carcinoma
04.22.2010
Pfizer Hosts Annual Meeting Of Shareholders; Declares 18-Cent Second-Quarter 2010 Dividend
04.15.2010
Pfizer Invites Public To Listen To Webcast Of April 22 Annual Meeting Of Shareholders
04.15.2010
Stemgent and Pfizer Announce Collaboration
04.13.2010
Pfizer Oncology To Present Over 30 Abstracts On Pre-Clinical And Clinical Research At The American Association For Cancer Research Annual Meeting
04.01.2010
Pfizer And Acacia Living Partner To Support Seniors In Living Independently

March 2010

03.31.2010
Pfizer Posts Details About Interactions With U.S. Physicians, Other Healthcare Professionals And Clinical Research Partners
03.29.2010
Pfizer Invites Public to View and Listen to Webcast of May 4 Conference Call with Analysts
03.23.2010
Pfizer Signs Long-Term Agreement To Supply Prevenar 13* To The World’s Poorest Countries
03.22.2010
Pfizer Animal Health Encourages Pet Owners to Consult Their Veterinarian for Safe, Effective Flea-and-Tick Control Recommendations
03.16.2010
Study Shows Prevenar 13* Is Immunogenic In Young Children Previously Vaccinated With Prevenar*
03.15.2010
Intensive Lipitor Therapy Was Associated With Reduced Risk Of Cardiovascular Events In Two High-Risk Patient Groups
03.11.2010
Pfizer Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
03.11.2010
Two Phase 3 Trials Of Sunitinib With Commonly Used Chemotherapies In Advanced Breast Cancer Did Not Meet The Primary Endpoint
03.04.2010
ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Was Statistically Superior To Enoxaparin In The Prevention Of Venous Thromboembolism Following Knee Replacement Surgery
03.03.2010
“Project Runway’s” Tim Gunn Returns to Address Psoriasis™ and Empower Patients to be Confident in Their Personal Style
03.02.2010
Pfizer And Medivation Announce Results From Two Phase 3 Studies In Dimebon (latrepirdine*) Alzheimer’s Disease Clinical Development Program
03.01.2010
Pfizer Invites Public To View And Listen To Webcast Of Investor Breakfast At Healthcare Conference

February 2010

02.25.2010
William Ringo, Pfizer’s Senior Vice President, Worldwide Business Development, Strategy And Innovation, To Retire
02.24.2010
CDC’s Advisory Committee On Immunization Practices Recommends Pfizer’s Prevnar 13™ Vaccine For The Prevention Of Invasive Pneumococcal Disease In Infants And Young Children In The U.S.
02.24.2010
Pfizer Receives FDA Approval for Prevnar 13™ for the Prevention of Invasive Pneumococcal Disease in Infants and Young Children
02.23.2010
Lilly, Merck, And Pfizer Join Forces To Accelerate Research And Improve Treatment Of Lung And Gastric Cancers In Asia
02.07.2010
Pfizer and Keas Partner to Help Consumers Take a More Active Role in Their Health and Wellness
02.04.2010
QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients
02.02.2010
Pfizer Reports Fourth-Quarter and Full-Year 2009 Results; Provides 2010 Financial Guidance and 2012 Financial Targets

January 2010

01.27.2010
New Pfizer Pipeline Shows Progress And Growth In Vaccines, Biologics And High-Priority Disease Areas
01.21.2010
Data Show Progression-Free Survival Advantage With Sutent® In Patients With Pancreatic Neuroendocrine Tumors
01.20.2010
Pfizer and Auxilium Announce Commencement of European Regulatory Review of XIAFLEXTM for the Treatment of Dupuytren’s Contracture
01.06.2010
Pfizer And Debiopharm Collaborate To Co-Develop Investigational Compound Tremelimumab (CP-675,206) In Advanced Melanoma
01.05.2010
Pfizer and Strides Arcolab to Collaborate on Generic Products
01.04.2010
Pfizer Invites Public To View And Listen To Webcast Of Pfizer Presentation At Healthcare Conference
01.04.2010
Pfizer Invites Public To Listen To Webcast Of Pfizer Discussion At Healthcare Conference

Page 44
Page 45
Current page 46
Page 47
Page 48

Media Resources & Contact Information

Media Contacts
Press Kits

Anyone may view our press releases, press statements, and press kits.

However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer media contacts may only respond to calls and emails from professional journalists.

Investors
Media
Careers
Partners

PfizerForAll
Healthcare Professionals
Grant Seekers
Business to Business

Privacy Statement
Accessibility Statement
Terms of Use
Contact Us

Glossary

© 2025 Pfizer Inc. All rights reserved

This information—including product information—is intended only for residents of the United States.

The products discussed herein may have different labeling in different countries.

Twitter
Facebook
Linked In
Instagram
Youtube